Pharma International provides global pharmaceutical regulatory consultancy services, with an emphasis on the emerging markets. Fully licensed by Swissmedic, Pharma International is authorised to trade in biotechnology, pharmaceuticals and medical devices internationally – as well as providing Swiss Qualified Person services. Seminars on regulatory affairs, especially Asia including ASEAN, China, Korea and India, are conducted regularly and can be adapted to in-house requirements.
Originally founded in 1996 and operating from laboratories in Royston, UK, Pharmagene Discovery Services (Pharmagene) is built upon the scientific knowledge, expertise and reputation of its legacy, and remains one of the earliest established companies to focus on human tissue-based research.
Pharmagene delivers tailored scientific solutions using human biospecimens in vitro to characterise disease and validate therapeutic targets & biomarkers to advance human health, from quantitative target expression, interrogation of spatial biology, functional cellular biology & bioassays, to biotherapeutic safety testing . The facility operates to GLP and is licenced by the UK Human Tissue Authority.
Pharmagene has created and curates an in-house human tissue biorepository to support research for its clients, and in addition offers sample processing and biostorage services.
With a wealth of knowledge of the human tissue research sector, and having conducted hundreds of studies for life science researchers around the world over the past three decades, the business is uniquely placed to support its clients to develop safe and efficacious new therapies and associated biomarkers more rapidly and with greater confidence.
Pharmagene delivers tailored scientific solutions using human biospecimens in vitro to characterise disease and validate therapeutic targets & biomarkers to advance human health, from quantitative target expression, interrogation of spatial biology, functional cellular biology & bioassays, to biotherapeutic safety testing . The facility operates to GLP and is licenced by the UK Human Tissue Authority.
Pharmagene has created and curates an in-house human tissue biorepository to support research for its clients, and in addition offers sample processing and biostorage services.
With a wealth of knowledge of the human tissue research sector, and having conducted hundreds of studies for life science researchers around the world over the past three decades, the business is uniquely placed to support its clients to develop safe and efficacious new therapies and associated biomarkers more rapidly and with greater confidence.
Regulatory Consultancy
PharmaMedic provides a comprehensive outsourced virtual medical and regulatory affairs service for start-ups, mid to late-stage biopharma, as well as consumer health organisations, medical device companies, and academic centres. We deliver our virtual medical and regulatory affairs solutions through a team of experienced pharmaceutical consultants. We provide a range of flexible services supporting start-ups, product launches, and large pharma teams.
For more information visit our website https://pharmamedic.co/
Download our capabilities brochure here https://pharmamedic.co/wp-content/uploads/2020/09/PMC-Capabilities.pdf
Watch our Member Showcase Video https://bit.ly/3rzlfvd
For more information visit our website https://pharmamedic.co/
Download our capabilities brochure here https://pharmamedic.co/wp-content/uploads/2020/09/PMC-Capabilities.pdf
Watch our Member Showcase Video https://bit.ly/3rzlfvd
PharmaVentures is a specialist healthcare consultancy which delivers practical and cost-effective solutions to clients world-wide in the pharmaceutical, biotechnology, healthcare, finance & related service sectors.. . . . Strategy, Analysis, Evaluation. Expert Reports, Due Diligence, Deal Benchmarking, Structuring & Negotiation, Product Partner Identification
No data available
Founded in the UK in 2002, Pharmidex provides high quality experimental preclinical ADMET/PK data, critical to the progression of drug discovery programmes. We have comprehensive in-house laboratory facilities as well as extensive in-vitro and in-vivo assay options. This enables us to provide tailored studies designed to meet individual project needs. Through extensive knowledge of drug discovery and development, Pharmidex has been able to deliver a high level of customer satisfaction and forge several strategic international alliances, focusing on operations in the following areas: in vitro ADMET, in-vivo Pharmacology, CNS Drug Discovery, Bioanalysis, Metabolite Identification, Bioimaging, and Zebrafish.
PhoreMost™ is focused on bringing more effective and affordable targeted medicines to patients. To achieve this aim, PhoreMost is developing a next-generation phenotypic screening technology that can discern the best new targets for future therapy and crucially, how to drug them. This has the potential to significantly increase the diversity of novel therapeutics for cancer and other unmet diseases. Based on the company's proprietary Protein Interference (PROTEINi®) technology, PhoreMost has developed SITESEEKER®; a platform that can systematically unmask cryptic druggable sites in the human genome and then link them to useful therapeutic functions in a live-cell context.
Watch our Member Showcase Video https://bit.ly/3rtFquQ
Having been established since 1992, PIA has grown to enjoy a significant reputation by working in partnership with our clients to provide a wide range of specialist insurance products for companies in the Life Science, Bio, Medical Technology and Healthcare sectors.
Being based in the Midlands, we are centrally placed to develop lasting relationships with businesses throughout the UK and Overseas.
Being based in the Midlands, we are centrally placed to develop lasting relationships with businesses throughout the UK and Overseas.